12:00 AM
 | 
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Advate octocog alfa regulatory update

Baxter said China's State Food and Drug Administration (SFDA) approved Advate octocog alfa to control and prevent bleeding episodes...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >